Takeda Pharmaceutical
TAK
#477
Rank
A$72.33 B
Marketcap
A$21.74
Share price
0.76%
Change (1 day)
5.32%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): A$3.07 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.52 Billion. In 2024 the company made an earning of A$3.35 Billion a decrease over its 2023 earnings that were of A$3.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$3.07 B-8.35%
2024 A$3.35 B-2.41%
2023 A$3.43 B-28.14%
2022 A$4.77 B-40.9%
2021 A$8.08 B78.24%
2020 A$4.53 B246.1%
2019 A$1.31 B-48.79%
2018 A$2.55 B-23.64%
2017 A$3.35 B21.7%
2016 A$2.75 B-253.01%
2015 -A$1.8 Billion-159.65%
2014 A$3.01 B13%
2013 A$2.66 B2.46%
2012 A$2.60 B-57.05%
2011 A$6.06 B-10.49%
2010 A$6.77 B-3.99%
2009 A$7.05 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.63 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.66 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$17.79 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.64 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-A$1.19 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.37 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
A$12.37 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$13.99 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$34.66 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA